Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Deadline
Morning deadline
HKEX Deadline
Noon deadline
Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Cross-Market Price Comparison

Other Listed Market Shenzhen (SZSE) — 可孚医疗
Other Market Stock Code301087
H-Share Offer PriceHK$ 39.33
Other Market PriceLoading...
Reference Exchange RateLoading...
H-Share Offer Price Premium/Discount vs Other MarketLoading...

Company Overview

Stock NameCofoe Medical
Stock Code01187
Company Full NameCofoe Medical Technology Co.,Ltd.
IndustryRobotics
Principal Activitiesprovider of home care medical devices in China
Listing Date2026-05-06
Listing Rules EraNew Rules (after Aug 2025)
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)Yuhua District Changsha City, Hunan Province PRC
Business Address (Hong Kong)Unit B, 22/F, Mai Luen Industrial Building 23-31 Kung Yip Street Kwai Chung, New Territories Hong Kong
Place of IncorporationPRC
Listing MethodGlobal Offering
Listing BoardMain Board
Websitehttps://www.cofoe.com.cn/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism B
Offer PriceHK$ 39.33 / shares
Offer Price RangeFinal offer price only, no range
Lot Size100 shares
Entry ThresholdHK$ 3,933
Par ValueTo be extracted
Offer Period2026-04-27 to 2026-04-30
Global Offering Shares27,000,000 shares
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone Share35.7%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 1,061,910,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 100 HK$ 3,933
2 lots 200 HK$ 7,866
3 lots 300 HK$ 11,799
4 lots 400 HK$ 15,732
5 lots 500 HK$ 19,665
6 lots 600 HK$ 23,598
7 lots 700 HK$ 27,531
8 lots 800 HK$ 31,464
9 lots 900 HK$ 35,397
10 lots 1,000 HK$ 39,330
15 lots 1,500 HK$ 58,995
20 lots 2,000 HK$ 78,660
25 lots 2,500 HK$ 98,325
30 lots 3,000 HK$ 117,990
35 lots 3,500 HK$ 137,655
40 lots 4,000 HK$ 157,320
45 lots 4,500 HK$ 176,985
50 lots 5,000 HK$ 196,650
60 lots 6,000 HK$ 235,980
70 lots 7,000 HK$ 275,310
80 lots 8,000 HK$ 314,640
90 lots 9,000 HK$ 353,970
100 lots 10,000 HK$ 393,300
200 lots 20,000 HK$ 786,600
300 lots 30,000 HK$ 1,179,900
400 lots 40,000 HK$ 1,573,200
500 lots 50,000 HK$ 1,966,500
600 lots 60,000 HK$ 2,359,800
700 lots 70,000 HK$ 2,753,100
800 lots 80,000 HK$ 3,146,400
900 lots 90,000 HK$ 3,539,700
1,000 lots 100,000 HK$ 3,933,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
2,000 lots 200,000 HK$ 7,866,000
3,000 lots 300,000 HK$ 11,799,000
4,000 lots 400,000 HK$ 15,732,000
5,000 lots 500,000 HK$ 19,665,000
6,000 lots 600,000 HK$ 23,598,000
7,000 lots 700,000 HK$ 27,531,000
8,000 lots 800,000 HK$ 31,464,000
9,000 lots 900,000 HK$ 35,397,000
10,000 lots 1,000,000 HK$ 39,330,000
13,500 lots 1,350,000 HK$ 53,095,500

Stock Connect Inclusion Analysis

HK Market Cap HK$ 813.8M
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusNet profit RMB 370.316 million
Period-End Cash BalanceRMB 1,294.6 million
Listing Expenses~HK$ 54,800,000
Listing Expenses / Funds Raised~5.2%
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 38.9
First Day OpenHK$ 39.84
First Day Change-1.09%
First Day Volume11185500.0
First Day Turnover428006000.0
Use of Proceeds
1、30.0%或約302.1百萬港元將用于全球拓展; 2、30.0%或約302.1百萬港元將用于持續的產品研發及技術創新,包括人工智能及物聯網應用; 3、20.0%或約201.4百萬港元將用于拓展國內銷售渠道及經銷網絡; 4、10.0%或約100.7百萬港元將用于品牌推廣及營銷活動; 5、10.0%或約100.7百萬港元將用于營運資金及一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669
Overall Coordinators (3)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 富途证券国际(香港)有限公司 CE AZT137
Joint Bookrunners (3)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 富途证券国际(香港)有限公司 CE AZT137
Joint Lead Managers (3)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 富途证券国际(香港)有限公司 CE AZT137

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Lens Technology (HK) Co., Limited 23,487,876 HKD — 2.21% — 6 months 2026-11-06
2 Changsha Yufeng Technology Co., Ltd. 7,826,670 HKD — 0.74% — 6 months 2026-11-06
3 Vision Capital Management Co., Ltd. and China Galaxy International Investment Company Limited (in connection with Vision Capital OTC Swaps) 54,696,231 HKD — 5.15% — 6 months 2026-11-06
4 Panjing Harbourview Investment Fund 15,657,273 HKD — 1.47% — 6 months 2026-11-06
5 FR M CONSULTING CO., LTD 19,574,541 HKD — 1.84% — 6 months 2026-11-06
6 HongKong HQD Industry Limited 39,149,082 HKD — 3.69% — 6 months 2026-11-06
7 Da Cheng International Asset Management Company Limited 78,302,097 HKD — 7.37% — 6 months 2026-11-06
8 Sinohealth Technology Holdings Limited 15,657,273 HKD — 1.47% — 6 months 2026-11-06
9 ODI TRUST LIMITED 39,149,082 HKD — 3.69% — 6 months 2026-11-06
10 Huang Xuelin 19,574,541 HKD — 1.84% — 6 months 2026-11-06
11 Dai Jun’an 50,971,680 HKD — 4.80% — 6 months 2026-11-06
12 Lu Qinchao 15,657,273 HKD — 1.47% — 6 months 2026-11-06

Directors & Management

PositionChinese nameEnglish Name
ChairmanMr. Zhang MinMr. Zhang Min
Company SecretaryXUE Xiaoqiao and HA Ching ChingXUE Xiaoqiao and HA Ching Ching
No director data available.

Major Shareholders

Major Shareholders & HoldingsMr. Zhang: 5.80% pre-IPO / 5.14% post-IPO; Ms. Nie: 1.67% / 1.48%; Changsha Xiezihao: 40.73% / 36.07%; Changsha Keyuan: 5.80% / 5.14%; Mr. Zhang Zhiming: 3.48% / 3.08% (total share capital, pre/post Global Offering).
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO drew intense retail interest with an oversubscription ratio of 399.08 times, signaling robust demand. However, the recorded hit rate of 0% — likely due to a full reallocation of the public tranche to the placing under the '机械B-无回补' mechanism — meant no public allocations were made, a highly atypical outcome. This divergence suggests that despite the enthusiasm, the allocation structure strongly favored institutional investors. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

The tier distribution reveals an unusual quirk: the 甲尾 (A-tail) group expected only 0.85 lots per application, while the 乙头 (B-head) group received a full 1.0 lot. This creates a perverse incentive where a larger B-head bid actually improved allocation efficiency over the highest A-tier, likely due to 'loose lot' rounding effects at the A/B boundary. The anomaly erodes the typical premium of smaller applications and warrants careful review of broker handling. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Mainland Chinese investors made up 65.6% of applicants, underscoring strong cross-border appetite for this Hong Kong robotics IPO. Men accounted for 64.9% and the average age was 41.4, reflecting a predominantly middle-aged male investor profile common in tech-focused offerings. This demographic skew may impact aftermarket liquidity and sentiment dynamics. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows Cofoe Medical (01187) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect